Cargando…
A Novel Machine Learning 13-Gene Signature: Improving Risk Analysis and Survival Prediction for Clear Cell Renal Cell Carcinoma Patients
SIMPLE SUMMARY: Clear cell renal cell carcinoma is a type of kidney cancer which comprises the majority of all renal cell carcinomas. Many efforts have been made to identify biomarkers which could help healthcare professionals better treat this kind of cancer. With extensive public data available, w...
Autores principales: | Terrematte, Patrick, Andrade, Dhiego Souto, Justino, Josivan, Stransky, Beatriz, de Araújo, Daniel Sabino A., Dória Neto, Adrião D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103317/ https://www.ncbi.nlm.nih.gov/pubmed/35565241 http://dx.doi.org/10.3390/cancers14092111 |
Ejemplares similares
-
GENTLE: a novel bioinformatics tool for generating features and building classifiers from T cell repertoire cancer data
por: Andrade, Dhiego Souto, et al.
Publicado: (2023) -
An integrated approach to identify bimodal genes associated with
prognosis in câncer
por: Justino, Josivan Ribeiro, et al.
Publicado: (2021) -
Association of CXCL13 and Immune Cell Infiltration Signature in Clear Cell Renal Cell Carcinoma
por: Jiao, Fangdong, et al.
Publicado: (2020) -
Machine learning-based prognosis signature for survival prediction of patients with clear cell renal cell carcinoma
por: Chen, Siteng, et al.
Publicado: (2022) -
Pathway Signature and Cellular Differentiation in Clear Cell Renal Cell Carcinoma
por: Tun, Han W., et al.
Publicado: (2010)